Jurkat Cells

Jurkat cells, which originated from the peripheral blood of a 14-year-old with T-cell acute lymphoblastic leukemia (T-ALL), are a well-known human T lymphocyte cell line commonly used in cell biology studies, particularly in cancer research and immune system disorder investigations. These cells play a crucial role in understanding various cellular processes, including cell death mechanisms, autophagy activity, and cytoplasmic transcription factors. Jurkat cells are commonly used in HIV research due to their expression of the CD4 receptor on their cell membrane. The CD4 receptor is a primary receptor that HIV uses to enter host cells. Because Jurkat cells express this receptor, they can be infected by HIV, making them a useful model for studying HIV's interactions with human T cells, which are a major target of the virus in the human body. The utilization of Jurkat cells in HIV activation and the HIV infection life cycle studies has significantly contributed to understanding the virus's interactions with human cells and has been instrumental in identifying potential targets for antiretroviral therapies. Jurkat cells further play a pivotal role in biomedical research, particularly in the evaluation of cytotoxicity and cell viability assays. This makes them indispensable for testing the effectiveness of potential cancer therapies and agents that modulate the immune response. By employing Jurkat cells, scientists can meticulously analyze the effects of cytotoxic compounds on the integrity and function of the cell membrane, including aspects related to cell membrane permeability and their transport properties. Furthermore, the presence of mutations in the Lck gene within Jurkat cells, which leads to sustained activation of T-cells, provides a unique model for in-depth studies of T-cell activation and signaling pathways. This is essential for understanding the complex processes of lymphocyte activation, which encompasses the cell cycle, cellular growth, and differentiation. Such insights are crucial for developing strategies to modulate immune responses in various diseases. The creation of a specific Jurkat cell derivative, known as Jurkat E6.1, has significantly advanced our comprehension of cellular mechanisms. This derivative offers a refined tool for probing into the nuanced behaviors of cell membranes and the physiological responses of individual cells under experimental conditions. Through the use of Jurkat E6.1 cells, researchers have been able to shed light on fundamental cellular processes and their implications for health and disease. In summary, Jurkat cells serve as invaluable tools in a wide range of research areas, from cancer biology to HIV infection studies, offering insights into cell biology, immune system function, and potential therapeutic interventions. Lymphoma cell lines, Blood, T-cell acute lymphoblastic leukemia, Growth Conditions: Suspension, Biosafety level: BSL 1